This brand name is authorized in United States. It is also authorized in Estonia, South Africa, Spain.
The drug CAPASTAT contains one active pharmaceutical ingredient (API):
1
|
UNII
9H8D3J7V21 - CAPREOMYCIN SULFATE
|
|
Capreomycin is active against human strains of Mycobacterium tuberculosis. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J04AB30 | Capreomycin | J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AB Antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1131107, 1584817 |
| ES | Centro de información online de medicamentos de la AEMPS | 45261 |
| US | FDA, National Drug Code | 17478-080 |
| ZA | Health Products Regulatory Authority | A40/20.2.3/0680 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.